Literature DB >> 10735620

Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cell cycle progression in rat hepatocytes by extracellular matrix.

M Nagaki1, A Sugiyama, T Naiki, Y Ohsawa, H Moriwaki.   

Abstract

BACKGROUND/AIMS: The extracellular matrix plays an essential role in the regulation of cell proliferation in different cell types. However, the regulation of cell cycle control in hepatocytes in response to growth factors and extracellular matrix signals is not well understood. The aims of this study were to investigate the expression of key cell cycle control elements, including cyclins, A and D1, and cyclin-dependent kinase inhibitors, p21 and p27, in rat hepatocytes in primary culture on dried collagen or Engelbreth-Holm-Swarm in the presence of epidermal growth factor.
METHODS: Hepatocytes prepared from Wistar rats were cultured on various extracellular matrix in Williams medium E in the presence or absence of 20 ng/ ml epidermal growth factor. DNA synthesis was measured by [3H]thymidine uptake and mRNA expression of cell cycle-related genes was determined by reverse transcription polymerase chain reaction.
RESULTS: Cyclins D1 and A mRNA levels were high at the G1/S boundary in epidermal growth factor-stimulated hepatocytes cultured on dried collagen. In contrast to spread cells, hepatocytes cultured on an Engelbreth-Holm-Swarm gel that were prevented from spreading failed to progress through the G1 phase and enter the S phase. This shape-dependent blockage of cell cycle progression correlated with the up-regulation of the cell cycle inhibitors p21 and p27.
CONCLUSIONS: Changes in hepatocyte-extracellular matrix interactions may control hepatocyte growth within the local microenvironment by modulating cell shape and regulating cyclins and the cyclin-dependent kinase inhibitors p21 and p27.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735620     DOI: 10.1016/s0168-8278(00)80401-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes.

Authors:  Yosuke Osawa; Masahito Nagaki; Yoshiko Banno; David A Brenner; Takahiko Asano; Yoshinori Nozawa; Hisataka Moriwaki; Shigeru Nakashima
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene.

Authors:  Hyun Jin Kwun; Kyung Lib Jang
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

3.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

4.  A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.

Authors:  Nobuaki Okumura; Tomohiko Koh; Yuichi Hasebe; Taiichiro Seki; Toyohiko Ariga
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

5.  Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication.

Authors:  Anne Corlu; Pascal Loyer
Journal:  Int J Hepatol       Date:  2012-10-03

6.  TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status.

Authors:  Sharon Sheahan; Christopher O Bellamy; Stephen N Harland; David J Harrison; Sandrine Prost
Journal:  BMC Cancer       Date:  2008-07-08       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.